Meeting Abstract: 2020 ASCO Annual Meeting I - ASCO Publications
May 25, 2020 · In the POLARGO study, the safety and efficacy of pola-R-GemOx vs R-GemOx alone will be assessed in pts with R/R DLBCL. Methods: POLARGO (MO40598; …
Polatuzumab vedotin as a salvage and bridging treatment in relapsed …
Jul 1, 2021 · Pola is an effective treatment in heavily pretreated patients with r/r LBCL, but long-term remissions are rare. Pola serves as a valuable bridging treatment to CAR T-cell therapy …
Pola X - Wikipedia
Pola X is a 1999 French drama film directed by Leos Carax and starring Guillaume Depardieu, Yekaterina Golubeva and Catherine Deneuve. The film is loosely based on the Herman …
Abstract - American Society of Hematology
Nov 5, 2021 · The ongoing POLARGO study is assessing the safety and efficacy of pola-R-GemOx compared with R-GemOx alone in pts with R/R DLBCL who are ineligible for stem cell …
Initial safety run-in results of the phase III POLARGO trial ...
Jun 2, 2022 · Adding polatuzumab vedotin to R-GemOx (Pola-R-GemOx) may improve outcomes for pts with a continued unmet medical need. The safety of polatuzumab vedotin and platinum …
Author notes - American Society of Hematology
Nov 13, 2019 · In the POLARGO study, we will assess the safety and efficacy of pola in combination with R-GemOx, compared with R-GemOx alone, in patients with R/R DLBCL.
Polatuzumab vedotin plus bendamustine and rituximab in …
Polatuzumab vedotin is an antibody–drug conjugate targeting CD79b to deliver a microtubule polymerization inhibitor, monomethyl auristatin E. 12-14 CD79b is a critical component of the …
Pola X (1999) - IMDb
Pierre, a young man of privilege whose anonymously-published novel is a hit and who is about to marry his beautiful blonde cousin Lucie, abandons everything when a brunette vagrant tells …
Cell-of-Origin Subtypes and Therapeutic Benefit from …
Aug 23, 2023 · As shown in Panel D, a phase 2, randomized, controlled trial (GO29265) and a phase 3, randomized, controlled trial (POLARIX) of regimens containing polatuzumab vedotin …
POLARGO: A Randomized Phase III Study Evaluating
Nov 13, 2019 · In the POLARGO study, we will assess the safety and efficacy of pola in combination with R-GemOx, compared with R-GemOx alone, in patients with R/R DLBCL.